AUM Cardiovascular (AUM) is a Minnesota based cardiovascular diagnostic company, created to bring a solution to costly and ineffective diagnosis of chest pain. AUM’s CADence device is a non-invasive, non-intrusive, fast, lower cost, easy-to-use, always-accessible device to rule-out obstructive coronary artery disease in patients with chest pain and risk factors. A $1B US market and margins of 81% make CADence poised for success.